Breadcrumb

Interlaced: Our Purpose Woven into Art

Interlaced: Our Purpose Woven into Art

Several yellow shoelaces interlaced together with writing

What might look like an ordinary wreath displayed at our U.S. headquarters is a powerful symbol of our collective hope and united purpose—to serve patients with compassion.

The focal point of “Interlaced” is a bow created from yellow and white shoelaces, dedicated by Daiichi Sankyo employees from the United States, Europe and Japan to people in their lives who have been touched by cancer. They include tributes to loved ones as well as messages of support to family members, friends and all patients living with the disease.

The shoelace dedication, woven into an artistic reminder of our collective compassion for patients, is the cornerstone of our In Their Shoes initiative, a series of opportunities to learn, grow and strengthen our patient mindset. The handwoven wreaths were inspired by traditional Shimenawa in honor of Daiichi Sankyo’s Japanese heritage. Shimenawa are lengths of straw or hemp rope used to demark sacred spaces and ward off disease in the Shinto religion. Shimenawa are traditionally displayed at the entrances of homes in Japan at the start of a new year.

Inspired by the courageous patients and fearless advocates who selflessly share their experiences with us, “Interlaced” is a daily reminder of their stories, our proud heritage and the compassion of our employees woven together.

OurStorySuggestions

Suggestions

Beyond Positive & Negative: The Spectrum of HER2 Expression in Cancer NEW

Cancer research and development is a dynamic and ever-evolving field. One significant area of focus is the role of HER2.

View more
Daiichi Sankyo’s HER2 Directed ADC Receives Industry’s Top Award

The Galien Foundation has recognized Daiichi Sankyo’s HER2 directed antibody drug conjugate (ADC) with the prestigious 2024 Prix Galien USA Award for Best Biotechnology Product.

View more
Translating Science for Patients—The Craft of a Passionate Advocate

For cancer patients, the science concerning their disease is sometimes outside of reach. As a patient-centric organization, we are on a mission to break down those barriers.

View more